Canada markets close in 4 hours 43 minutes

Acer Therapeutics Inc. (ACER)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.0000-0.0100 (-0.50%)
As of 10:58AM EST. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 26.90M
Enterprise Value 21.51M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)28.86
Price/Book (mrq)12.43
Enterprise Value/Revenue 23.90
Enterprise Value/EBITDA -1.22

Trading Information

Stock Price History

Beta (5Y Monthly) 1.09
52-Week Change 3-19.28%
S&P500 52-Week Change 324.02%
52 Week High 35.3900
52 Week Low 31.6800
50-Day Moving Average 32.3860
200-Day Moving Average 32.7044

Share Statistics

Avg Vol (3 month) 3299.34k
Avg Vol (10 day) 379.28k
Shares Outstanding 514.31M
Implied Shares Outstanding 6N/A
Float 88.52M
% Held by Insiders 115.34%
% Held by Institutions 129.41%
Shares Short (Nov. 14, 2021) 4270.07k
Short Ratio (Nov. 14, 2021) 43.04
Short % of Float (Nov. 14, 2021) 42.86%
Short % of Shares Outstanding (Nov. 14, 2021) 41.89%
Shares Short (prior month Oct. 14, 2021) 4353.73k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Sep. 20, 2017
Ex-Dividend Date 4N/A
Last Split Factor 296:1000
Last Split Date 3Sep. 20, 2017

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2020
Most Recent Quarter (mrq)Sep. 29, 2021


Profit Margin 0.00%
Operating Margin (ttm)-1,953.61%

Management Effectiveness

Return on Assets (ttm)-45.87%
Return on Equity (ttm)-271.41%

Income Statement

Revenue (ttm)900k
Revenue Per Share (ttm)0.06
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -17.51M
Net Income Avi to Common (ttm)-17.19M
Diluted EPS (ttm)-1.2440
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)14.15M
Total Cash Per Share (mrq)0.99
Total Debt (mrq)176.9k
Total Debt/Equity (mrq)8.17
Current Ratio (mrq)0.81
Book Value Per Share (mrq)0.15

Cash Flow Statement

Operating Cash Flow (ttm)-2.59M
Levered Free Cash Flow (ttm)8.06M